FDA Provisions Push Growth in Clinical Trial Registry
American Journal of Health-system Pharmacy 2009 June 1; 66(11): 973-974
Showing items related by title, author, creator and subject.
Medicare's Revised Clinical Trail Policy and Clinical Trial-Related Provisions of FDAAA: What Is a Sponsor to Do? Dobbins, Kirk; Scanlon, Kay (2007)
A National Survey of Provisions in Clinical-Trial Agreements Between Medical Schools and Industry Sponsors Schulman, Kevin A.; Seils, Damon M.; Timbie, Justin W.; Sugarman, Jeremy; Dame, Lauren A.; Weinfurt, Kevin P.; Mark, Daniel B.; Califf, Robert M. (2002-10-24)BACKGROUND: Concerned about threats to the integrity of clinical trials in a research environment increasingly controlled by private interests, the International Committee of Medical Journal Editors (ICMJE) has issued ...
Researchers' Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements With Industry Sponsors Mello, Michelle M.; Clarridge, Brian R.; Studdert, David M. (2005-07)We conducted a mail survey of 884 U.S. medical school faculty active in clinical research to elicit their views about the acceptability of provisions in contracts for industry-sponsored clinical trials that would restrict ...